NIH-funded research R01 grant

Investigating immune cells in gum disease and diabetes

Official title: Single-cell RNA-sequencing for functional analysis of monocytes and macrophages in periodontitis

Funded at University of California, San Francisco · NIH-10997400 · Data updated 2026-11-12

This study is looking at how certain immune cells work in people with gum disease and type 2 diabetes, hoping to find out more about their role in inflammation and disease, which could help create better treatments for those affected.

More Periodontitis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startAugust 1, 2024
Project endNovember 30, 2028
Funding year2025
Award (this year)$614,425
NIH project number5R01DE032433-03
Project IDNIH-10997400 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with periodontitis and type 2 diabetes, especially those from minority backgrounds.

Less likely to help

Patients without periodontitis or type 2 diabetes, or those not belonging to the affected demographic groups, may not benefit from this research.

What this research studies

This research focuses on understanding how specific immune cells, particularly monocytes and macrophages, behave in patients with periodontitis, a chronic gum disease, and type 2 diabetes. By using advanced single-cell RNA sequencing techniques, the study aims to uncover the differences in immune responses among diverse populations, especially those disproportionately affected by these conditions. The research will analyze how these immune cells contribute to inflammation and disease progression, potentially leading to better-targeted treatments for affected individuals.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for periodontitis and type 2 diabetes, particularly for minority and low socio-economic status populations.

How similar studies have gone: Previous research has shown promising results in understanding immune responses in similar contexts, indicating that this approach could yield valuable insights.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Momen Heravi, Fatemeh — University of California, San Francisco
  • Study coordinator: Momen Heravi, Fatemeh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.